Approximately 40 per cent of all cancers are linked with modifiable...
Category:
Health
Latest
Centre asks employees to take ‘Y-Break – Yoga at office chair’ to de-stress, refresh and refocus
"Y-Break at workplace was introduced by the Ministry of AYUSH with...
Can ChatGPT help sexually assaulted, suicidal individuals?
"One of the dominant health issues of the decade is equipping the...
COVID-19: India records lowest daily cases in over six months
The number of people who have recuperated from the disease surged to 99,75,958 pushing the national recovery rate to 96.32 per cent,while the COVID-19 case fatality rate stands at 1.45 per cent.
There are 2,31,036active coronavirus infections in the country which comprises 2.23per cent of the total caseload,the data stated.
India gets its first women’s team in disaster combat
“The first women rescuers’ team is already on ground. Recently, the UP government requisitioned an NDRF team and they (women) went there (Garh Mukteshwar). The team handled the rescue boats and related equipments,” NDRF director general S N Pradhan told PTI in an interview.
“These personnel have all the skills to be called complete rescuers,” he said.
Consumers feel higher importance of sanitisation; cloth wash frequency rises amid pandemic: Survey
Commenting on the findings, Whirlpool of India Vice-President (Marketing) K G Singh said, ”People today are more vigilant of their health and hygiene than ever before.” An official spokesperson from Kantar said the survey clearly indicates the stress and worry around sanitisation of clothes.
Approval of COVID vaccine lends strength to optimism on health, eco fronts: FinMin report
India, the report said, ”has been successful in bending the COVID-curve till now, with reducing weekly/daily infections, rising recovery rate (now at around 95 per cent) and one of the world’s lowest case fatality rates”. The downside risk, however, remains due to the spread of the UK variant and fatigue from social distancing guidelines, it said, adding the emphasis on continued observation of ‘COVID appropriate’ behaviour with the due exercise of caution and surveillance needs to be sustained.
China doubles down on COVID narrative as WHO investigation looms
Raina MacIntyre, head of the Kirby Institute’s Biosecurity Research Program in Australia, said the investigation needed to draw “a comprehensive global picture of the epidemiological clues”, including any evidence COVID-19 was present outside of China before December 2019.
A COVID-19 shot for $150? Online scams surge as slow vaccine rollout frustrates
Scams include emails promising entry to supposedly secret lists for early vaccine access and robocallers impersonating government agencies. Message boards on the so-called dark web have added COVID-19 vaccines to more traditional illicit goods for sale.
Indian vaccine makers end spat, pledge ‘smooth rollout’ of COVID-19 shots
The approval for Bharat Biotech’s COVAXIN, developed with a government research body, faced criticism from industry experts and others as the company has yet to release efficacy and safety data, and it still has a Phase III trial underway.
Private sector should be an ally In India’s big vaccine push
The ugly truth about India is that its problems rarely revolve around production; too often they center on distribution. We produce more than enough food but can’t distribute it to our population, so we have a third of the world’s malnourished children. While we generate more than enough electricity, our distribution system is inefficient and unprofitable – and so businesses and homes are plagued by constant power cuts.
Coronavirus vaccine to cost $3-4 to govt; $6-8 in private market: SII
“We want the vaccine to be affordable and accessible to all. The government of India will receive it at a far more affordable price of USD 3-4, since they will be buying in a larger volume,” said Adar Poonawalla,CEO,Serum Institute of India,
Sufficient Covid-19 Vaccines For First Phase Of Vaccination Drive: V K Paul
“Our first phase (of vaccination) comprises priority groups with a high risk of mortality and our healthcare and frontline workers. For them, we believe, we have enough (Covid-19 vaccine) stockpile,” V K Paul,Chairman of National Expert Group On Vaccine Administration for Covid-19, told PTI in an interview.